The listing of PROMOMED shares on the Moscow Stock Exchange is one year old

On July 12, 2025, one year has passed since the date of the initial public offering of shares of the PROMOMED biopharmaceutical Company (PRMD) on the Moscow Stock Exchange.

The Company's market capitalization currently stands at 86.6 billion rubles, and the share of shares in free float is 6.7%.

The shareholder base of PJSC PROMOMED has grown by 250% since the start of exchange trading and currently has more than 35.9 thousand private and institutional investors.

The Company's securities are included in the second-tier quotation list of the Moscow Stock Exchange and are included in the settlement databases.The Broad Market Moscow Exchange Index, the IPO Moscow Exchange Index, and others.

Shares of PJSC PROMOMED are available at the main, evening and morning trading sessions of the Moscow Stock Exchange stock market, as well as at an additional weekend session.

Alexander Yefremov, CEO of PJSC PROMOMED, commented:

"The public offering of shares has given a new impetus to the implementation of a rapid growth strategy focused on the development, production and commercialization of innovative medicines. When we entered the stock market, the macroeconomic situation was extremely turbulent, nevertheless, we made specific commitments to investors, and today, summing up the results of the first year, we can say with confidence that we not only fulfilled our promises to the market, but exceeded them in a number of key areas.

We would like to share our joy over what we have done and achieved with our esteemed Colleagues from the Moscow Stock Exchange and express our sincere gratitude to them.: you have invested your knowledge and experience, time and a piece of your soul in us. We saw and felt this, and we have justified your investment with our actions. Today, we continue to implement advanced solutions for leadership in key therapeutic segments and sustainable growth of the Company's shareholder value, just as we discussed a year ago."

Natalia Loginova, Director of the Moscow Exchange's Department for Dealing with Issuers:

"Despite all the challenges of the current economic situation, the Russian pharmaceutical industry demonstrates dynamic development and high potential, which is of obvious interest to investors. Proper use of capital market opportunities allows companies to attract the necessary funds for further development, strengthen their market positions in highly competitive conditions and increase their attractiveness as an employer. Congratulations to PROMOMED on the anniversary of its listing on the Moscow Stock Exchange and wish you further success."